Delivery Order SPE2DB22D2211-SPE2DB24FNPP9

Award Date 5/28/24
Potential Completion Date 5/29/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, the Corporate Office Division of the major pharmaceutical distribution company Amerisourcebergen Corporation. The $2,033.64 firm fixed-price delivery order is for the supply of the prescription medication Repatha (140 mg/mL), with a completion date of June 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,033.64 delivery order is for Repatha 140 mg/ml Sureclick, a specialty medication. The contract has an ultimate completion date of November 2, 2023 and is a firm fixed-price delivery order with no set-aside requirements. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a broad...
This federal contract award, valued at $6,111.37, was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract covers the delivery of Repatha, a 140 mg/mL SureClick medication, with a completion date of September 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,455.31 firm fixed-price delivery order is for the drug Repatha (140 mg/mL SureClick), with a completion date of February 25, 2025. The contract is not designated as a set-aside award. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,577.97 firm-fixed-price delivery order is for the supply of Repatha 140 mg/mL SureClick medication. The contract has an ultimate completion date of March 3, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $3,990.67, is for the supply of the pharmaceutical product Repatha 140 mg/mL. The award does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $2,057.78 firm fixed price delivery order is for the supply of Repatha 140 mg/ml Sureclick medication. The contract has a completion date of May 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025. This single-award...
This federal contract award, issued by the Defense Logistics Agency (DLA), was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,203.16 firm fixed-price delivery order is for the supply of Repatha 140 mg/mL SureClick, a specialty cardiovascular medication. This contract represents a component of AmerisourceBergen's broader $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Repatha 140 mg/mL syringes to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,016.82 firm-fixed-price delivery order falls under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities. As the prime contractor, Amerisourcebergen will...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,051.98 firm fixed-price delivery order is for the supply of Repatha 140 mg/mL SureClick medication. The contract has an ultimate completion date of January 30, 2025 and does not include any set-aside requirements. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FNPP9
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation, is for the delivery of Repatha, a 140 mg/mL medication, to the Defense Logistics Agency (DLA). The $2,352.63 firm fixed-price delivery order has a completion date of May 29, 2024.

Amerisourcebergen holds two Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999.00 and $750,000.00 respectively. These IDCs serve as the primary vehicles for Amerisourcebergen to provide a broad range of pharmaceutical products and medical supplies, including specialty drugs, generic medications, and critical care materials, to support various government medical programs and facilities. This specific delivery order does not have a set-aside designation.

Generated 8/27/24, 9:58 AM